NOS Life Sciences
Pharmaceuticals - Tres Cantos, Community of Madrid, Spain
NOS Life Sciences Employees
NOS Life Sciences Details
Parkinson's Disease is a neurodegenerative and severely incapacitating condition that progressively reduces the ability to move.PD affects 13 M of people worldwide. With 85 new cases every hour, Parkinson's is estimated to reach 32 M by 2050.PD creates a global estimated burden of $ 120 B.NOS Life Sciences is a pre-clinical-stage company devoted to the development of therapeutics to address the most relevant unmet needs in Parkinson's, namely motor symptoms and disease progression.These therapies are based on a technology platform that combines extensive breakthrough research on neuro-signaling molecules and proprietary nano-delivery system.Other molecules in the pipeline at pre-clinical stage target different neurological conditions presenting clear unmet needs.
NOS Life Sciences Technologies
Advertising Networks
Google AdSense
Hosting
Google Cloud Hosting
Other
Mobile Friendly